Beurs gesloten -
Nasdaq Stockholm
17:29:54 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
220,5
SEK
|
-3,92%
|
|
-1,78%
|
+4,01%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
7.621
|
7.322
|
7.757
|
5.462
|
5.057
|
5.259
|
-
|
-
|
Bedrijfswaarde
1 |
7.678
|
7.353
|
7.763
|
5.456
|
5.000
|
5.134
|
5.047
|
4.906
|
K/w-verhouding
|
76,8
x
|
81,9
x
|
61,9
x
|
46,2
x
|
38,8
x
|
31,2
x
|
24,2
x
|
19,5
x
|
Dividendrendement
|
-
|
0,24%
|
0,62%
|
0,87%
|
1,06%
|
1,12%
|
1,36%
|
1,61%
|
Marktkapitalisatie/omzet
|
16,5
x
|
15,5
x
|
13,7
x
|
8,54
x
|
7,47
x
|
6,74
x
|
5,91
x
|
5,13
x
|
Bedrijfswaarde/omzet
|
16,6
x
|
15,6
x
|
13,7
x
|
8,53
x
|
7,38
x
|
6,58
x
|
5,67
x
|
4,79
x
|
Bedrijfswaarde/EBITDA
|
52,3
x
|
51,5
x
|
39,6
x
|
27,5
x
|
24,2
x
|
19,8
x
|
16
x
|
13
x
|
Bedrijfswaarde/FCF
|
72,3
x
|
117
x
|
68
x
|
81,1
x
|
45,1
x
|
37
x
|
31,4
x
|
25
x
|
FCF Yield
|
1,38%
|
0,86%
|
1,47%
|
1,23%
|
2,22%
|
2,71%
|
3,19%
|
3,99%
|
Price to Book
|
21,9
x
|
17
x
|
14,3
x
|
8,51
x
|
7,06
x
|
6,33
x
|
5,38
x
|
4,43
x
|
Aantal aandelen (in duizenden)
|
23.852
|
23.852
|
23.852
|
23.852
|
23.852
|
23.852
|
-
|
-
|
Referentieprijs
2 |
319,5
|
307,0
|
325,2
|
229,0
|
212,0
|
220,5
|
220,5
|
220,5
|
Datum van publicatie
|
5/02/20
|
4/02/21
|
4/02/22
|
8/02/23
|
7/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
461,8
|
471,4
|
565,6
|
639,3
|
677,3
|
780,1
|
889,9
|
1.025
|
EBITDA
1 |
146,7
|
142,9
|
196,2
|
198,4
|
206,8
|
259,3
|
315,6
|
378
|
Bedrijfsresultaat (EBIT)
1 |
126,6
|
110,3
|
162,7
|
158,3
|
167,1
|
216,1
|
273,6
|
335,7
|
Operationele Marge
|
27,41%
|
23,39%
|
28,77%
|
24,75%
|
24,66%
|
27,7%
|
30,75%
|
32,75%
|
Resultaat voor belastingen (EBT)
1 |
129,2
|
112,2
|
158,3
|
148,4
|
164,2
|
214
|
275,9
|
335,9
|
Nettowinst (verlies)
1 |
99,17
|
89,48
|
125,3
|
118,3
|
130,3
|
169,1
|
218,1
|
270,2
|
Nettomarge
|
21,48%
|
18,98%
|
22,16%
|
18,51%
|
19,24%
|
21,68%
|
24,5%
|
26,36%
|
WPA
2 |
4,160
|
3,750
|
5,250
|
4,960
|
5,460
|
7,077
|
9,130
|
11,33
|
Free Cash Flow
1 |
106,2
|
63,06
|
114,2
|
67,27
|
110,9
|
138,9
|
160,8
|
196
|
FCF-marge
|
23,01%
|
13,37%
|
20,19%
|
10,52%
|
16,37%
|
17,81%
|
18,06%
|
19,12%
|
Kasstroomconversie (ebitda)
|
72,4%
|
44,13%
|
58,21%
|
33,91%
|
53,62%
|
53,59%
|
50,94%
|
51,85%
|
Kasstroomconversie (nettowinst)
|
107,12%
|
70,47%
|
91,11%
|
56,85%
|
85,11%
|
82,17%
|
73,72%
|
72,54%
|
Dividend per aandeel
2 |
-
|
0,7500
|
2,000
|
2,000
|
2,250
|
2,473
|
3,007
|
3,550
|
Datum van publicatie
|
5/02/20
|
4/02/21
|
4/02/22
|
8/02/23
|
7/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Omzet
1 |
164,2
|
162,4
|
183,6
|
141
|
152,3
|
139,1
|
169,7
|
167,9
|
200,6
|
194
|
192,7
|
225,3
|
EBITDA
1 |
60,49
|
59,04
|
61,48
|
29,45
|
48,4
|
34,55
|
56,03
|
43,44
|
72,79
|
64,18
|
65,15
|
83,03
|
Bedrijfsresultaat (EBIT)
1 |
51,76
|
49,82
|
52,43
|
16,96
|
39,06
|
25,04
|
46,19
|
33,27
|
62,55
|
53,97
|
54,57
|
72,15
|
Operationele Marge
|
31,53%
|
30,67%
|
28,56%
|
12,02%
|
25,65%
|
18%
|
27,23%
|
19,82%
|
31,18%
|
27,82%
|
28,32%
|
32,02%
|
Resultaat voor belastingen (EBT)
1 |
51,04
|
48,62
|
46,86
|
12,85
|
40,09
|
24,36
|
44,34
|
32,16
|
63,37
|
54,89
|
52,09
|
74,36
|
Nettowinst (verlies)
1 |
39,76
|
38,4
|
37,25
|
10,38
|
32,3
|
19,21
|
34,71
|
25,96
|
50,43
|
43,29
|
41,68
|
56,52
|
Nettomarge
|
24,22%
|
23,64%
|
20,29%
|
7,36%
|
21,2%
|
13,81%
|
20,46%
|
15,46%
|
25,14%
|
22,31%
|
21,63%
|
25,08%
|
WPA
2 |
1,670
|
1,610
|
1,560
|
0,4400
|
1,350
|
0,8100
|
1,460
|
1,090
|
2,110
|
1,776
|
1,817
|
2,392
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2,300
|
Datum van publicatie
|
4/02/22
|
10/05/22
|
20/07/22
|
26/10/22
|
8/02/23
|
4/05/23
|
20/07/23
|
25/10/23
|
7/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
57,8
|
30,5
|
6,37
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
-
|
-
|
-
|
5,56
|
56,9
|
125
|
212
|
353
|
Hefboom (schuld/ebitda)
|
0,3936
x
|
0,2136
x
|
0,0325
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
106
|
63,1
|
114
|
67,3
|
111
|
139
|
161
|
196
|
ROE (netto-inkomsten/eigen vermogen)
|
31,1%
|
23%
|
25,8%
|
20%
|
19,2%
|
21,8%
|
23,8%
|
24,5%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
13,8%
|
14,3%
|
16,9%
|
19%
|
19,2%
|
Totale activa
1 |
-
|
-
|
-
|
858,5
|
910,2
|
998
|
1.147
|
1.405
|
Nettoactief per aandeel
2 |
14,60
|
18,00
|
22,80
|
26,90
|
30,00
|
34,80
|
41,00
|
49,80
|
Cashflow per aandeel
|
-
|
2,980
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
2,67
|
8,07
|
84,3
|
70
|
85,5
|
70
|
78,7
|
86,3
|
Capex/omzet
|
0,58%
|
1,71%
|
14,91%
|
10,95%
|
12,63%
|
8,97%
|
8,84%
|
8,42%
|
Datum van publicatie
|
5/02/20
|
4/02/21
|
4/02/22
|
8/02/23
|
7/02/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
220,5
SEK Gemiddelde koersdoel
257,5
SEK Spread / Gemiddelde doel +16,78% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +4,01% | 480 mln. | | -12,91% | 19,08 mld. | | -46,21% | 2,65 mld. | | +18,15% | 1,87 mld. | | -3,12% | 1,61 mld. | | +23,78% | 1,21 mld. | | -10,69% | 1,02 mld. | | -20,89% | 905 mln. | | -7,14% | 716 mln. | | -18,10% | 682 mln. |
Medisch diagnose- & testmateriaal
|